"Effect of post-kidney transplant diabetes mellitus on long-term outcomes in a cohort of pediatric kidney transplant recipients from 2005 to 2022." Survival analysis.
Maria Alejandra Calvo-Herrera, Angelica Maria Serna-Campuzano, María Carolina Isaza-Lopez, Esteban Villegas-Arbeláez, Luisa Fernanda Rojas-Rosas, Lina Maria Serna-Higuita, Carolina Lucia Ochoa-García
{"title":"\"Effect of post-kidney transplant diabetes mellitus on long-term outcomes in a cohort of pediatric kidney transplant recipients from 2005 to 2022.\" Survival analysis.","authors":"Maria Alejandra Calvo-Herrera, Angelica Maria Serna-Campuzano, María Carolina Isaza-Lopez, Esteban Villegas-Arbeláez, Luisa Fernanda Rojas-Rosas, Lina Maria Serna-Higuita, Carolina Lucia Ochoa-García","doi":"10.1136/bmjpo-2024-002710","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-transplantation diabetes mellitus and carbohydrate intolerance (PTDM/iCHO) are complications following solid organ transplantation, which significantly increases the risk of graft loss and mortality. However, data concerning long-term outcomes in paediatric kidney transplant recipients with PTDM/iCHO are scarce. This study aimed to evaluate the risk of graft loss in paediatric kidney transplant recipients with PTDM or iCHO compared with non-PTDM/iCHO.</p><p><strong>Methods: </strong>The study cohort included patients aged <18 who underwent a kidney transplant in a transplant centre from 2005 to 2022. The primary outcome was graft survival loss; secondary outcomes were acute rejection, renal function and mortality. Cumulative incidence of graft loss and acute rejection was estimated, considering death a competing risk. Fine and Gray's proportional subdistribution hazard model was used to analyse the effect of PTDM/iCHO status on the event.</p><p><strong>Results: </strong>Seventy-six paediatric kidney transplant recipients were included. The incidence of PTDM and iCHO was 6.6% and 9.2%, respectively. Patients with PTDM/iCHO had a significantly higher cumulative graft loss incidence than those without (34.4% vs 13.9% at 36 months, p<0.008). Multivariable analysis revealed a threefold increased risk of graft loss in patients with PTDM/iCHO (HR<sub>adjusted</sub> 3.33, 95% CI 1.19 to 9.30, p=0.022). PTDM/iCHO was associated with a higher incidence of acute rejection (33.3% vs 14.5% at 1 year, p=0.025). Patients with PTDM/iCHO also exhibited significantly worse eGFR at all time points compared with patients without PTDM/iCHO (p=0.036) CONCLUSION: Patients with PTDM and iCHO had a higher risk of graft loss and lower renal function in paediatric kidney transplant recipients. This justifies close monitoring of metabolic complications in these patients.</p>","PeriodicalId":9069,"journal":{"name":"BMJ Paediatrics Open","volume":"8 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683984/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Paediatrics Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjpo-2024-002710","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Post-transplantation diabetes mellitus and carbohydrate intolerance (PTDM/iCHO) are complications following solid organ transplantation, which significantly increases the risk of graft loss and mortality. However, data concerning long-term outcomes in paediatric kidney transplant recipients with PTDM/iCHO are scarce. This study aimed to evaluate the risk of graft loss in paediatric kidney transplant recipients with PTDM or iCHO compared with non-PTDM/iCHO.
Methods: The study cohort included patients aged <18 who underwent a kidney transplant in a transplant centre from 2005 to 2022. The primary outcome was graft survival loss; secondary outcomes were acute rejection, renal function and mortality. Cumulative incidence of graft loss and acute rejection was estimated, considering death a competing risk. Fine and Gray's proportional subdistribution hazard model was used to analyse the effect of PTDM/iCHO status on the event.
Results: Seventy-six paediatric kidney transplant recipients were included. The incidence of PTDM and iCHO was 6.6% and 9.2%, respectively. Patients with PTDM/iCHO had a significantly higher cumulative graft loss incidence than those without (34.4% vs 13.9% at 36 months, p<0.008). Multivariable analysis revealed a threefold increased risk of graft loss in patients with PTDM/iCHO (HRadjusted 3.33, 95% CI 1.19 to 9.30, p=0.022). PTDM/iCHO was associated with a higher incidence of acute rejection (33.3% vs 14.5% at 1 year, p=0.025). Patients with PTDM/iCHO also exhibited significantly worse eGFR at all time points compared with patients without PTDM/iCHO (p=0.036) CONCLUSION: Patients with PTDM and iCHO had a higher risk of graft loss and lower renal function in paediatric kidney transplant recipients. This justifies close monitoring of metabolic complications in these patients.
背景:移植后糖尿病和碳水化合物不耐受(PTDM/iCHO)是实体器官移植后的并发症,显著增加移植物丢失和死亡的风险。然而,关于PTDM/iCHO儿童肾移植受者的长期预后的数据很少。本研究旨在评估患有PTDM或iCHO的儿童肾移植受者与非PTDM/iCHO患者相比移植物丢失的风险。结果:76名儿童肾移植受者被纳入研究队列。PTDM和iCHO的发病率分别为6.6%和9.2%。PTDM/iCHO患者的累积移植物丢失发生率明显高于无PTDM/iCHO患者(36个月时34.4% vs 13.9%, p校正后为3.33,95% CI 1.19 ~ 9.30, p=0.022)。PTDM/iCHO与较高的急性排斥发生率相关(1年时33.3% vs 14.5%, p=0.025)。与没有PTDM/iCHO的患者相比,PTDM/iCHO患者在所有时间点的eGFR也明显更差(p=0.036)。结论:PTDM和iCHO患者在儿科肾移植受者中有更高的移植物丢失风险和更低的肾功能。这证明密切监测这些患者的代谢并发症是合理的。